© 2003 Fellowship of Postgraduate Medicine
BEST PRACTICE
Management of irritable bowel syndrome
Royal Victoria Infirmary, Newcastle upon Tyne
Correspondence to:
Correspondence to:
Dr John Mansfield, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP; UK;
John.mansfield{at}nuth.northy.nhs.uk
The diagnosis of irritable bowel syndrome (IBS) is made on clinical grounds with appropriate limited investigations to exclude organic disease. IBS is common and may have a significant impact on a patients quality of life. Psychological symptoms are common. IBS may benefit from pharmacological and non-pharmacological management. Specific measures should be directed towards the dominant symptoms of constipation or diarrhoea. Several new drugs are currently under evaluation and may prove valuable for subgroups of patients with IBS. Successful management requires a combination of reassurance and explanation about the natural history of the condition.
Keywords: irritable bowel syndrome; functional bowel disease; psychosocial; fibre
Abbreviations: 5-HT3, serotonin-3; 5-HT4, serotonin-4; IBS, irritable bowel syndrome; SSRI, specific serotonin reuptake inhibitors
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Bergmann, K A
(2003). Update on irritable bowel syndrome. Postgrad. Med. J.
79: 715-715
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
